Reverse Transcriptase News and Research

RSS
Qatari study finds BNT162b2 vaccine effectiveness waning 6 months after second dose

Qatari study finds BNT162b2 vaccine effectiveness waning 6 months after second dose

Study shows an association between initial SARS-CoV-2 viral load and disease severity

Study shows an association between initial SARS-CoV-2 viral load and disease severity

AstraZeneca COVID-19 vaccine safe and effective in phase 3 U.S., Chile, and Peru trial

AstraZeneca COVID-19 vaccine safe and effective in phase 3 U.S., Chile, and Peru trial

Using nasopharyngeal microbiota as early biomarker in patients with COVID-19

Using nasopharyngeal microbiota as early biomarker in patients with COVID-19

Children are less likely to get long-COVID, yet still at risk, study finds

Children are less likely to get long-COVID, yet still at risk, study finds

Persistent leukocyte changes three months after mild SARS-CoV-2 infection

Persistent leukocyte changes three months after mild SARS-CoV-2 infection

Damaging DNA builds up in the eyes to drive blinding age-related macular degeneration

Damaging DNA builds up in the eyes to drive blinding age-related macular degeneration

Effect of biologic therapy on COVID-19 in children suffering from rheumatic diseases

Effect of biologic therapy on COVID-19 in children suffering from rheumatic diseases

A retrospective surveillance study of Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccination in Israel

A retrospective surveillance study of Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccination in Israel

The effectiveness of mRNA BNT162b2 vaccine in reducing severe COVID-19: Evidence from Germany

The effectiveness of mRNA BNT162b2 vaccine in reducing severe COVID-19: Evidence from Germany

Monoclonal antibodies may reduce hospital stay, but not mortality in COVID-19

Monoclonal antibodies may reduce hospital stay, but not mortality in COVID-19

Study shows SARS-CoV-2 breakthrough infections 18-fold lower than rate of infections among unvaccinated

Study shows SARS-CoV-2 breakthrough infections 18-fold lower than rate of infections among unvaccinated

Further evidence of safety and efficacy of mRNA-1273 vaccine in preventing symptomatic COVID-19 and SARS-CoV-2 infection

Further evidence of safety and efficacy of mRNA-1273 vaccine in preventing symptomatic COVID-19 and SARS-CoV-2 infection

SARS-CoV-2 delta variant has higher viral RNA levels and increased infectivity, suggests study

SARS-CoV-2 delta variant has higher viral RNA levels and increased infectivity, suggests study

Novel spike NTD mutations in SARS-CoV-2 Delta variant associated with increased viral loads and immune evasion

Novel spike NTD mutations in SARS-CoV-2 Delta variant associated with increased viral loads and immune evasion

Analysis of 2021 Ebola outbreak reveals long-term dormant infections

Analysis of 2021 Ebola outbreak reveals long-term dormant infections

A variant analysis approach for SARS-CoV-2 in wastewater samples

A variant analysis approach for SARS-CoV-2 in wastewater samples

Prior symptomatic COVID-19 enhances mRNA vaccine response

Prior symptomatic COVID-19 enhances mRNA vaccine response

Dynamics of healthcare-associated SARS-CoV-2 infections revealed with whole genome sequencing

Dynamics of healthcare-associated SARS-CoV-2 infections revealed with whole genome sequencing

Guidelines: Summer camp returns to normal during COVID-19

Guidelines: Summer camp returns to normal during COVID-19

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.